文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

普通人群中罗马 IV 肠易激综合征患者的医疗保健利用情况。

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.

机构信息

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Academic Unit of Gastroenterology & Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

出版信息

United European Gastroenterol J. 2021 Dec;9(10):1178-1188. doi: 10.1002/ueg2.12153. Epub 2021 Oct 1.


DOI:10.1002/ueg2.12153
PMID:34599559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8672084/
Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms for healthcare seeking behaviours in this patient group are poorly understood. OBJECTIVE: To describe healthcare utilization and identify factors associated with seeking healthcare amongst IBS subjects in the general population. METHODS: An internet survey was completed by 6,300 individuals equally distributed between United States, United Kingdom and Canada. The Rome IV diagnostic questionnaire was used to identify subjects with IBS. Data on demographics, medical history, gastrointestinal (GI) and non-GI symptoms, quality of life and health care consumption was collected. RESULTS: A total of 5,931 subjects were included; 274 (4.6%) IBS subjects and 5657 (95.3%) non-IBS controls. IBS subjects reported more doctor consultations for both GI and other health problems as well as increased use of medication and rate of abdominal surgery (appendectomy excluded). Having healthcare insurance or access to free public healthcare (adjusted odds ratio (AOR) 4.49, 95% confidence interval (CI) 1.31-15.44), followed by high frequency of bloating (AOR 2.65, 95% CI 1.42-4.93) and increasing age (AOR 1.02, 95% CI 1.01-1.05) were found to be independently associated with being an IBS consulter while doctor-diagnosed IBS subjects were more likely to be female and to report abdominal pain as their most bothersome GI symptom than other consulters with IBS. CONCLUSION: IBS subjects have higher healthcare utilization than non-IBS controls, medication use and abdominal surgery included. Furthermore, consulters with and without an IBS diagnosis differ in sex distribution and symptom profiles. Hence, awareness of the possibility of unnecessary medical and surgical treatment in IBS subjects and a sex-related diagnostic bias by doctors is warranted.

摘要

背景:肠易激综合征(IBS)在全球范围内高发,但该患者群体寻求医疗保健的机制尚不清楚。

目的:描述普通人群中 IBS 患者的医疗保健利用情况,并确定与寻求医疗保健相关的因素。

方法:通过互联网对 6300 名来自美国、英国和加拿大的个体进行了一项调查。采用罗马 IV 诊断问卷来识别 IBS 患者。收集了人口统计学、病史、胃肠道(GI)和非 GI 症状、生活质量和医疗保健消费的数据。

结果:共纳入 5931 名受试者;274 名(4.6%)IBS 患者和 5657 名(95.3%)非 IBS 对照者。IBS 患者报告他们因 GI 和其他健康问题看医生的次数更多,并且使用药物和腹部手术的频率更高(不包括阑尾切除术)。有医疗保险或可以获得免费公共医疗保健(调整后的优势比(AOR)4.49,95%置信区间(CI)1.31-15.44),其次是腹胀的高频率(AOR 2.65,95%CI 1.42-4.93)和年龄的增加(AOR 1.02,95%CI 1.01-1.05)与成为 IBS 就诊者独立相关,而医生诊断为 IBS 的患者更有可能是女性,并且报告腹痛是他们最困扰的 GI 症状,而不是其他 IBS 就诊者。

结论:IBS 患者的医疗保健利用率高于非 IBS 对照组,包括药物使用和腹部手术。此外,有和没有 IBS 诊断的就诊者在性别分布和症状特征上存在差异。因此,需要意识到 IBS 患者存在不必要的医疗和手术治疗的可能性,以及医生存在与性别相关的诊断偏见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/b9eff7755c15/UEG2-9-1178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/eac6eda5cace/UEG2-9-1178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/314a11e4f756/UEG2-9-1178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/b9eff7755c15/UEG2-9-1178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/eac6eda5cace/UEG2-9-1178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/314a11e4f756/UEG2-9-1178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/b9eff7755c15/UEG2-9-1178-g001.jpg

相似文献

[1]
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.

United European Gastroenterol J. 2021-12

[2]
Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.

Gastroenterology. 2020-1-7

[3]
Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study.

Neurogastroenterol Motil. 2018-11-4

[4]
Prevalence and impact of self-reported irritable bowel symptoms in the general population.

United European Gastroenterol J. 2018-12-22

[5]
Why do subjects with irritable bowel syndrome seek health care for their symptoms?

Scand J Gastroenterol. 2007-10

[6]
Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan.

Aliment Pharmacol Ther. 2005-6-15

[7]
Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.

Eur J Gastroenterol Hepatol. 2009-2

[8]
Comorbidity and use of health-care services among irritable bowel syndrome sufferers.

Scand J Gastroenterol. 2007-7

[9]
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Am J Gastroenterol. 2017-11-14

[10]
Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.

Lancet Gastroenterol Hepatol. 2018-2-1

引用本文的文献

[1]
The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.

Transl Med UniSa. 2023-12-22

[2]
Results from a Cross-Sectional Observational Study Examining Irritable Bowel Syndrome Patients Six Months After Finishing Their Participation in the ViIBS Trial.

Nutrients. 2024-11-15

[3]
A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context.

Glob Adv Integr Med Health. 2024-7-25

[4]
Synbiotics as Treatment for Irritable Bowel Syndrome: A Review.

Microorganisms. 2024-7-21

[5]
Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial.

Nutrients. 2024-5-16

[6]
What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework.

BMJ Open. 2024-3-21

[7]
The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.

Nutrients. 2023-9-15

[8]
Is C-section a risk factor for the early onset of irritable bowel syndrome?

Med Pharm Rep. 2023-4

[9]
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.

Gut Microbes. 2023

[10]
Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.

United European Gastroenterol J. 2022-9

本文引用的文献

[1]
Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.

Gastroenterology. 2021-1

[2]
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.

Gastroenterology. 2021-1

[3]
Management of Chronic Abdominal Distension and Bloating.

Clin Gastroenterol Hepatol. 2021-2

[4]
Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders.

Curr Gastroenterol Rep. 2018-11-5

[5]
Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.

United European Gastroenterol J. 2018-11

[6]
Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.

Am J Gastroenterol. 2018-9-25

[7]
Health problems associated with irritable bowel syndrome: analysis of a primary care registry.

Aliment Pharmacol Ther. 2018-3-24

[8]
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.

Gastroenterology. 2017-12-22

[9]
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Am J Gastroenterol. 2017-11-14

[10]
Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.

Am J Gastroenterol. 2017-5-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索